Abstract
Vacuolar ATPases (V-ATPases, V1Vo-ATPases) are rotary motor proton pumps that acidify intracellular compartments, and, when localized to the plasma membrane, the extracellular space. V-ATPase is regulated by a unique process referred to as reversible disassembly, wherein V1-ATPase disengages from Vo proton channel in response to diverse environmental signals. Whereas the disassembly step of this process is ATP dependent, the (re)assembly step is not, but requires the action of a heterotrimeric chaperone referred to as the RAVE complex. Recently, an alternative pathway of holoenzyme disassembly was discovered that involves binding of Oxidation Resistance 1 (Oxr1p), a poorly characterized protein implicated in oxidative stress response. Unlike conventional reversible disassembly, which depends on enzyme activity, Oxr1p induced dissociation can occur in absence of ATP. Yeast Oxr1p belongs to the family of TLDc domain containing proteins that are conserved from yeast to mammals, and have been implicated in V-ATPase function in a variety of tissues. This brief perspective summarizes what we know about the molecular mechanisms governing both reversible (ATP dependent) and Oxr1p driven (ATP independent) V-ATPase dissociation into autoinhibited V1 and Vo subcomplexes.
Keywords: Vacuolar H+-ATPase, V1-ATPase, Vo proton channel, Reversible disassembly, Oxr1p, TLDc domain, Subunit H, Subunit C, Peripheral stalk, Protein-protein interaction, ADP inhibition
Graphical Abstract

The vacuolar H+-ATPase is regulated by reversible disassembly into autoinhibited V1-ATPase and Vo proton channel subcomplexes. Here we discuss possible physiological roles of our recent discovery that disassembly of the yeast V-ATPase is induced by binding of Oxr1p, a TLDc domain containing protein implied in the protection against oxidative stress.
Introduction
The eukaryotic vacuolar H+-ATPase (V-ATPase; V1Vo-ATPase) is a ubiquitous proton pump found on the endomembrane system of virtually all eukaryotic cells where the enzyme functions to acidify the lumen of subcellular compartments.[1–5] In polarized cells such as renal α intercalated cells or bone lining osteoclasts, V-ATPases can also be localized to the plasma membrane to acidify the extracellular milieu. V-ATPase belongs to the family of rotary motor ATPases, which also includes the F-ATP synthases found in mitochondria, bacteria, and chloroplasts, the archaeal A-ATPases/synthases, and various A/V-like ATPases found mainly in eubacteria.[6–8] Depending on the type of motor, its location, and the organism, rotary ATPases either function as ATP synthases that are powered by ion (sodium or proton) gradients generated during e.g. oxidation of food stuffs, or as ion-pumping ATPases, whose function is to establish and maintain transmembrane ion-motive force for secondary transport processes. Despite their diversity in function, all rotary ATPases share a common architecture and mechanism of energy coupling: synthesis or hydrolysis of ATP on the membrane extrinsic F1-, A1- or V1-ATPases is coupled to the translocation of ions across the membrane integral Fo, Ao or Vo ion channels via rotation of a central rotor subcomplex. Most rotary ATPases are reversible because they can be driven by an ion gradient to synthesize ATP, or they can hydrolyze ATP to pump ions across the lipid bilayer. The eukaryotic V-ATPase, however, only operates in the direction of proton pumping under physiological conditions (Figure 1A).
Figure 1.

The eukaryotic vacuolar H+-ATPase and regulation by disengagement of V1-ATPase and Vo proton channel. (A) Schematic of the architecture and mechanism of the yeast V-ATPase. (B) Regulation by reversible disassembly (left side) and Oxr1p mediated disassembly (right side).
V-ATPase is regulated by a unique process referred to as reversible disassembly, a mechanism that has so far not been found for any other rotary ATPase family member. First observed in baker’s yeast and insects, V-ATPase reversible disassembly is a mode of regulation wherein the holoenzyme dissociates into V1 and Vo,[9,10] with both subcomplexes becoming autoinhibited[11–13] (Figure 1B, left side). In yeast, for example, reversible disassembly occurs in response to changes in nutrient availability or extracellular pH.[14,15] As V-ATPases are major consumers of ATP, regulated disassembly into autoinhibited V1 and Vo is thought to preserve both energy and transmembrane pH gradients. Evidence for reversible disassembly as a regulatory mechanism has also been found in higher organisms, including in human cells.[16–19] Here, the process is fine-tuned to the need for proton pumping in specific tasks such as maturation of dendritic cells,[20] TOR signaling,[21,22] neurotransmitter loading into synaptic vesicles,[23] and nutrient sensing.[24] While the process of reversible disassembly has been extensively characterized on the cellular level in yeast,[25] our understanding of the molecular events that trigger the disassembly or reassembly on the level of the enzyme is only now beginning to emerge.[26,27] From these studies, we know that while disassembly requires active enzyme and intact microtubules,[28,29] (re)assembly is dependent on the heterotrimeric chaperone complex, RAVE.[30,31] More recently, a novel factor capable of inducing enzyme disassembly was discovered in yeast. Here, binding of Oxidation resistance 1 protein (Oxr1p), a poorly characterized protein that has been associated with resistance to oxidative stress, was shown to cause disassembly of the V-ATPase in vitro, with concomitant formation of a V1-ATPase complex bound to Oxr1p[32] (Figure 1B, right side). Importantly, unlike in vivo reversible disassembly, which requires active enzyme[14], the Oxr1p-induced disengagement of V1 from Vo in vitro was found to occur without added ATP.[32] Yeast Oxr1p is a 273-residue globular protein that contains a C-terminal TLDc domain (TLDc stands for Tre2/Bub2/Cdc16 (TBC), lysin motif (LysM), Domain catalytic), which has several homologs in mammals, including nuclear receptor coactivator 7 (NCOA7), OXR1, TLDC2, TBC1D24, mammalian enhancer of AKT1–7 (mEAK7), and interferon induced protein 44 (IFI44).[33,34] All of the mammalian TLDc domain-containing proteins except IFI44 have now been shown to directly interact with V-ATPase,[35–39] and several have also been linked to V-ATPase function.[40,41] In the following sections, we will briefly review the structure and mechanism of the V-ATPase followed by a summary of our current knowledge of the mechanisms of reversible and Oxr1p induced disassembly of the yeast V-ATPase.
The eukaryotic V-ATPase
Unlike related ATP synthases and bacterial rotary ion pumps, eukaryotic V-ATPase reversibly disassembles into V1-ATPase and Vo proton turbine in vivo, with the degree of assembly or disassembly governed by the physiological state of the cell.[1,2] Regulated enzyme dissociation is a unique property of the eukaryotic V-ATPase and while certain structurally related bacterial rotary ATPases are sometimes referred to as “V-ATPases”, such as, for example, the enzyme from Enterococcus hirae,[42,43] this article uses V-ATPase strictly in the context of the eukaryotic enzyme. Early biochemical studies of eukaryotic V-ATPases were conducted with enzymes from bovine brain, chromaffin granules, and plants such as lemon and carrot.[44] However, due to ease of genetic manipulation and generation of biomass for enzyme purification, baker’s yeast (Saccharomyces cerevisiae) has emerged as a powerful model system for the study of the highly conserved eukaryotic V-ATPase. Moreover, whereas complete loss of V-ATPase in higher organisms is embryonic lethal,[45] lack of a functional enzyme in yeast results in a conditional phenotype referred to as Vma-, as the cells can grow at acidic but not elevated pH in presence of calcium or zinc ions.[46] Early studies of the structure of the holoenzyme, its V1 and Vo subcomplexes, as well as individual subunits and subunit complexes were conducted using negative stain electron microscopy,[47–49] X-ray crystallography,[50–54] and NMR spectroscopy.[55] More recent advances in cryo electron microscopy (cryoEM) have provided near-atomic or secondary structure resolution models of the V-ATPases from a variety of organisms, including the enzymes from yeast,[27,32,56–58] rat[59] and bovine brain,[60] pig kidney,[39] human cell culture,[38,61] and lemon.[62] Pioneering cryoEM structural work by the Rubinstein lab resolved populations of purified yeast V-ATPase that showed the central rotor subcomplex halted in three angular positions each 120° apart, with the three populations referred to as rotary states 1–3.[56] The combination of the earlier biochemical and structural studies and the more recent cryoEM data has provided a wealth of information on the structure and mechanism of this highly dynamic molecular machine.
Structure of the V-ATPase
The cryoEM structure of lipid nanodisc reconstituted yeast V-ATPase has been determined at an overall resolution of ~4.2 Å for rotary state 1 (Figure 2A, left panel).[32] The cytosolic headpiece is called the V1-ATPase, or V1, with the membrane integral proton turbine referred to as Vo proton channel, or Vo. The subunit composition of V1 is A3B3CDE3FG3H, and Vo is made of the single copy subunits adef and ten highly hydrophobic proteolipids (c,c’,c”) that are arranged in a ring (c-ring; in yeast c8,c’c” and in mammals c9c”).[6,63,64] Yeast Vo contains an additional polypeptide, the C-terminal transmembrane (TM) ⍺ helix of the assembly factor Voa1p (Figure 2A, middle panel).[58] Two additional polypeptides are found in mammalian Vo: Ac45 (ATP6AP1) and pro-renin receptor (ATP6AP2), both anchored to the enzyme via their C-terminal TM ⍺ helices within the central cavity of the c-ring.[59,61] Ac45 contains a glycosylated globular domain with b-prism fold that protrudes from the c-ring towards the lumen or extracellular space.[61] While Ac45 has been implicated in assembly and trafficking of the complex in mammals,[65] the role of the pro-renin receptor is unclear. In yeast, the C-terminal TM ⍺ helix of Voa1p occupies an equivalent position to that observed for mammalian Ac45. However, Voa1 is not considered a core subunit of the yeast enzyme as it is not essential for assembly or function.[66] The catalytic hexamer of V1 is composed of three subunit AB heterodimers that are arranged around a central cavity, with three catalytic ATP binding sites at alternating AB interfaces (Figure 2B). The central cavity of the catalytic hexamer is filled by part of the D subunit, which, together with subunit F forms the central rotor of V1 (Figure 2A, middle panel). The bottom of the DF subcomplex protrudes by ~45 Å from the catalytic hexamer to bind subunit d of Vo, thereby coupling V1’s central rotor to Vo’s c-ring (Figure 2A, middle panel). Each of the ten c-ring proteolipids contributes one essential glutamic acid residue that is located mid-membrane facing the lipid bilayer (Figure 2C). Subunit a of the Vo contains an N-terminal cytosolic (aNT) and a membrane integral C-terminal domain (aCT) (Figure 2A, right panel). aCT features two aqueous half-channels, one for proton entry from the cytosol, and one for proton release into the lumen (or extracellular space for V-ATPases found in the PM of higher eukaryotes) (Figure 2C). aCT’s interface to the c-ring is constituted by two tilted TM α helices that contain several polar amino acids, including two essential arginine residues. Besides the DF:d connection, V1 and Vo are linked by three peripheral stators that are each constituted by a parallel heterodimer of E and G subunits (EG1–3) (Figure 2A, left panel), which are engaged in a right-handed coiled coil for much of their length starting from their N-termini.[52] EG’s C-terminal globular domains are linked to the N-terminal domains of the B subunits at the top of V1, with their N-termini connected to aNT and subunit C. C and aNT together form the collar at the V1-Vo interface, with each having two globular domains separated by a coiled coil. aNT is divided into proximal and distal domains (proximal is relative to aCT), and C is organized into head (Chead) and foot (Cfoot), with Cfoot bound to aNT’s distal domain (Figure 2A, right panel). Peripheral stators EG1 and EG2 link subunit a to the catalytic hexamer through aNT’s proximal and distal domains, respectively, with EG3 connected to the collar by way of Chead. The H subunit is folded in an N-terminal α helical solenoid (HNT), and a C-terminal α helical globular domain (HCT) (Figure 2A, right panel). HNT is bound to the middle part of EG1, and HCT rests on the coiled coil of aNT. The e and f subunits of the Vo each contain two α helical TMS that are packed against aCT facing the lipid bilayer (Figure 2A, right panel).
Figure 2.

Structure of the yeast vacuolar ATPase in lipid nanodisc. (A) Left panel: CryoEM structure of lipid nanodisc yeast reconstituted V-ATPase in rotary state 1[32] (PDBID 7FDA). Middle panel: V-ATPase central rotor subcomplex. Two of the c subunits are not shown to allow a view inside the c-ring cylinder. Right panel: V-ATPase stator subcomplex. (B) Cross section of states 1–3 at the level of the phosphate binding loops (P-loops) of the V1 A subunits as indicated with the dashed line in (A), left panel. The blue arrowheads point to the open catalytic sites, with the P-loops highlighted in blue. The closed and half-closed catalytic sites are indicated by black arrowheads. (C) Cross section of the V-ATPase Vo at the level indicated by the dashed line in (A), left panel. For details, see text.
V-ATPase subunit isoforms –
A complicating aspect of V-ATPase structure and function is the presence of subunit isoforms. In yeast, the 100 kDa a subunit of the Vo is expressed as two isoforms, Vph1p and Stv1p.[67] The Stv1p and Vph1p polypeptides are ~50% identical and found in complexes retained in the Golgi or trafficked to the vacuole, respectively, with the signal peptide responsible for the differential trafficking found in the isoforms’ N-terminal domains.[68] Biochemical experiments in yeast revealed that only the Vph1p containing V-ATPases in the vacuole are subject to reversible disassembly, but not the Stv1p containing enzymes in the Golgi. However, when Stv1p is overexpressed and pushed to the vacuole in a VPH1 deletion strain, some reversible disassembly is also observed for the Stv1p containing enzymes,[69] indicating that the propensity of a given V-ATPase to undergo reversible disassembly may depend more on the biological membrane the enzyme is residing on than on isoform content. In higher organisms, a little more than half of the subunits are expressed as multiple isoforms, including the four isoforms of subunit a found in mammals (a1–4).[70] While tissue enrichment is observed for some isoforms (such as a4 and B1 in the kidney, epididymis, and the olfactory epithelium), most are ubiquitously expressed.[2] The synaptic vesicle V-ATPase, which has been shown to undergo reversible disassembly,[23] contains subunit isoforms that are ubiquitous in nature. However, whether different isoform combinations lead to differential propensities for regulated enzyme disassembly in mammals is not known.
Mechanism of ATP hydrolysis driven proton pumping
V-ATPases couple hydrolysis of ATP on the membrane extrinsic V1 to ion translocation across the membrane integral Vo by way of a central rotor constituted by V1 and Vo subunits. V1-ATPase is a stepping motor; ATP hydrolysis at the three catalytic AB interfaces drives rotation of the DF heterodimer in steps of 120°, resulting in rotary states 1–3 as resolved in cryoEM structures of the yeast enzyme[32,56] (Figure 2B). The DF heterodimer, through its interaction with subunit d, then rotates the c-ring past aCT’s two almost horizontal TM a helices, which contain several polar residues that are critical for proton pumping.[71] The biochemical and cryoEM structural data suggest that protons are guided from the cytosolic half-channel towards a conserved glutamic acid residue (Glu721 in yeast Vph1p) from where they are transferred to a deprotonated glutamate on the c-ring (Figure 2C). Once protonated, the c-ring glutamic acid residue can now exit the aCT:c-ring interface and enter the lipid bilayer, allowing another c subunit to exit the bilayer into the aCT:c-ring interface and transfer its proton to a conserved glutamate (Glu789) at the entry site to aCT’s lumen half-channel. The now deprotonated c-ring glutamate is then guided by a conserved histidine (His796) towards the two conserved arginine residues (Arg735,799) to form a salt bridge. Salt bridge formation results in an energy minimum, and for the c-ring to continue the rotation requires the driving force of the V1-ATPase. Since the V-ATPase has three catalytic sites and ten proteolipids, this means that on average 3.3 protons are pumped for each ATP molecule hydrolyzed.
Structural features of autoinhibited V1
Whereas V1 is a highly active ATPase when coupled to Vo (~300 ATP × s−1),[72] V1 that is dissociated from the membrane no longer hydrolyzes MgATP with a measurable rate.[12] Biochemical experiments in yeast showed that subunit H is responsible for inhibiting V1’s MgATPase activity.[12] However, while V1 purified from a yeast strain from which H was deleted (V1ΔH) readily hydrolyzes MgATP, the activity quickly decays due to retention of inhibitory MgADP in a catalytic site1.[12,53] MgADP inhibition, which is a conserved feature of the catalytic headpieces of rotary ATPases, is a stable, off-catalytic pathway conformation that is distinct from competitive product (ADP) inhibition. To obtain a more detailed picture of the mechanism of autoinhibition, we obtained a crystal structure of V1 purified from a yeast strain deleted for the C subunit (V1ΔC).[53] The structure showed that autoinhibited V1 is halted in rotary state 2, with HCT rotated from its position on aNT to bind the rotor subunit D and the C-terminal domain of one of the B subunits. The structure thus suggested that autoinhibition is due to interfering with the rotation of the central rotor, reminiscent of the mode of inhibition by the C-terminal α helical domain of the ε subunit in the bacterial F-ATPase.[73] Supporting biochemical data showed that while V1ΔH is essentially nucleotide free, autoinhibited V1 has at least one tightly bound ADP in a catalytic site. Taken together, this indicated that the HCT:V1 interaction also served to stabilize inhibitory MgADP in a catalytic site. The interaction of HCT and D was seen to be mediated by a loop in HCT that is not conserved in higher organisms including mammals. Indeed, replacing yeast HCT with that from the human enzyme to generate a chimeric H subunit (Hchim, containing yeast HNT and human HCT) restored V1’s ability to hydrolyze MgATP.[53] Moreover, since HCT’s binding site on aNT in the holoenzyme is conserved, Hchim was not only able to complement deletion of H in yeast,[53] but replacing wild type H with Hchim also allowed in vitro assembly of holo V-ATPase from V1 and Vo, a process that does not occur at a significant rate with wild type V1.[74]
However, the interpretation of HCT’s binding site as seen in the crystal structure of (V1ΔC) was recently disputed based on single particle cryoEM structures of wild type V1 and V1ΔC, which showed HCT in contact with the N-termini of EG2[27] (Figure 3A). Here, the same site in HCT that is bound to aNT in V1Vo (Figure 3B) is seen interacting with EG2’s N-termini in membrane detached and autoinhibited V1 (Figure 3A, see dashed circle)2. The authors of that study suggested that this arrangement of HCT seen in the cryoEM structure is responsible for autoinhibition, an interpretation supported by mutagenesis of a residue in the HCT:EG2 interface that restored V1’s MgATPase activity. On the other hand, yet another HCT conformation can be seen in the more recent cryoEM structures of citrus V-ATPase that resembled the conformation as seen in the crystal structure of V1ΔC,[62] suggesting that HCT is able to adopt and sample multiple conformations and binding sites. More work will be needed to understand the physiological significance of the different conformations of HCT and their roles in V-ATPase regulation.
Figure 3.

Structure of autoinhibited yeast V1-ATPase. Upper panel: CryoEM structure of autoinhibited V1 in state 2 (PDBID 7TMM),[27] highlighting the interaction between HCT and the N-termini of EG2. Lower panel: Region of the cryoEM structure of nanodisc bound holo V-ATPase in state 2 (PDBID 7FDB),[32] highlighting the binding site of HCT on aNT.
Structural features of autoinhibited Vo
The structure of the isolated Vo has been determined by cryoEM,[57,58] with the highest resolution structure obtained for the lipid nanodisc reconstituted complex.[75] The structures show that autoinhibited Vo is halted in rotary state 3, with the essential glutamates of c” and the neighboring c subunit forming salt bridges with the two conserved arginines in aCT’s tilted TM α helices. The overall structure of isolated Vo resembles the structure of the Vo in the state 3 holoenzyme[32,56] (Figure 4A, left panel), except for the conformation of aNT. In the holoenzyme, aNT is seen at a peripheral position where it binds Cfoot and EG2 (Figure 4B). Once V1 disengages from Vo, aNT moves towards the central rotor to bind subunit d (see arrow in Figure 4B, right panel), thereby making a structural link between the rotor (c-ring) and the stator (subunit a) (Figure 4A, right panel). Unlike the F-ATPase Fo proton channel, which is a leaky proton pore in isolation,[76] the Vo proton channel is sealed to protons once V1 disengages.[13] It has been suggested that inhibition of proton leakage across free Vo is caused by the interaction between aNT and d.[77] However, while one study using purified yeast Vo showed that selective removal of d did not open the channel,[78] experiments with Vo from plant V-ATPase indicated some restoration of proton flow upon d removal.[79] Bafilomycin sensitive channel function was also partially restored by exposing reconstituted bovine Vo to low pH, however, the subunit composition of the acid treated Vo was not further analyzed.[80] Taken together, while the interaction between aNT and d that is only observed in isolated Vo is clearly inhibitory, there may be additional features that restrict c-ring rotation in absence of V1.[75]
Figure 4.

Structure of autoinhibited yeast Vo proton channel. (A) CryoEM structure of autoinhibited Vo in lipid nanodisc (PDBID 6M0R)[75] as seen parallel to the membrane (left panel) and from the cytoplasm towards the bilayer (right panel). The interaction of aNT and d is highlighted by the dashed pink circles. (B) CryoEM structure of yeast holo V-ATPase in state 3 (PDBID 7FDC)[32] seen as in the panels in (A). The conformational change of aNT from a peripheral location in V1Vo to its binding site on d in free Vo is highlighted by the pink arrow in the view from the cytoplasm towards the membrane.
How Oxr1p binds V1 and induces V-ATPase dissociation
We recently obtained cryoEM structures of yeast V-ATPase assembled in vitro from V1ΔH, Vo in lipid nanodisc (VoND), and recombinant subunits Hchim and C[32] (Figure 2). Besides holoenzyme, the analysis revealed a population of V1ΔH complexes bound to subunit C and a hitherto unseen component that we identified as Oxr1p. Yeast Oxr1p is a poorly characterized 273 residue polypeptide that is composed of a C-terminal TLDc domain plus a 60 residue N-terminal segment predicted to be largely disordered. The structure shows that V1 is halted in rotary state 1, with Oxr1p wedged between the C-terminal domains of a non-catalytic AB heterodimer, the N-termini of EG2, and subunit C (Figure 5A).[32] Sequence and structure analysis showed that many of the residues that form the V1-Oxr1p binding site are conserved on both Oxr1p and V1 subunits.[32] Subsequent in vitro biochemical experiments revealed that recombinant Oxr1p inhibited V1DH’s MgATPase activity in a subunit C-dependent manner, blocked in vitro assembly of the holoenzyme, and caused rapid release of V1 from the vacuolar membrane.[32] None of these inhibitory activities by Oxr1p required MgATP, suggesting that it is the greater stability of the resulting V1(C)Oxr1p complex that provides the required driving force for breaking the protein-protein interactions at the V1-Vo interface. A closer analysis of the Oxr1p binding site revealed that much of the interaction is mediated by the C-terminal domain of the B subunit that is part of the open catalytic site (Figure 5A). Since inhibition of V1ΔH’s MgATPase activity by Oxr1p in absence of C is weak,[32] this suggests that the interaction with C and EG2 is required for the formation of a high-affinity binding site. However, to engage with Oxr1p that is bound to B, both C and EG2 have to undergo significant shifts from their binding sites in V1Vo;[32] these structural changes appear to be sufficient for breaking of the V1-Vo interface. We and others have previously shown that the V1-Vo interface is constituted by multiple weak interactions except for the high-affinity interface between EG3’s N-termini and Chead.[26,81,82] Moreover, from a crystal structure of the yeast heterotrimeric EGChead complex we speculated that disassembly is initiated by destabilizing the ternary junction between the distal domain of aNT, the N-termini of EG2, and Cfoot.[52] However, what was missing in our model was the identity of the trigger that would destabilize this ternary junction. Our recent structural and biochemical data suggest that one such trigger may be Oxr1p binding.
Figure 5.

Structure of yeast V1 in complex with Oxr1p and the C subunit and comparison to mEAK7 bound human V-ATPase. (A) Two views of the cryoEM structure of V1(C)Oxr1 (PDBID 7FDE),[32] highlighting Oxr1p’s binding site formed by EG2, subunit C, and the B subunit of the open catalytic site. V1(C)Oxr1 is halted in rotary state 1. (B) CryoEM structure of human V-ATPase in complex with mEAK7 (PDBID 7UNF).[38] Left panel, same view as in left panel 5A. Right panel, like yeast Oxr1p, mEAK7 binds the N-termini of a EG heterodimer and the C-terminal domain of a B subunit with the open catalytic site conformation. However, note that mEAK7 binds to peripheral stalk EG3 rather than EG2 as Oxr1p. (C) Zoomed in views of the Oxr1p binding site (upper panel) and comparison to the same site in state 1 V1Vo without Oxr1p bound (PDBID 7FDA). (D) Zoomed in view of the mEAK7 binding site (upper panel), and comparison to the same site in state 2 V1Vo (PDBID 6WM3).
Whereas Oxr1p is the only TLDc domain containing protein in yeast, so far six TLDc domain-containing homologs have been identified in the human genome: OXR1, NCOA7, mEAK7, TBC1D24, TLDC2 and IFI443. While most of these proteins have N- or C-terminal extensions, it has been shown for some of them that their TLDc domains alone are sufficient for function.[33,41,83] In fact, the shortest splice variants of mammalian NCOA7 and OXR1, like yeast Oxr1p, are composed almost entirely of their TLDc domains.[84,85] Notably, both NCOA7 and OXR1 were identified as high-scoring binding partners in an interactomics study of the kidney V-ATPase.[35] More recently, a direct interaction was observed between the V-ATPase and mammalian NCOA7, OXR1, TBC1D24, mEAK7, and TLDC2.[36] Further, mEAK7 has been identified in V-ATPase preparations from human cells[38,86] and pig kidney.[39] The accompanying cryoEM structures showed the enzymes halted in rotary state 2, with mEAK7 bound to the C-terminal domains of the non-catalytic subunit AB pair located behind peripheral stator EG3 (Figure 5B).[38,39,86] Unlike Oxr1p, mEAK7 has a short C-terminal a helix that inserts between the catalytic site to contact subunit D. Thus, while both mEAK7 and Oxr1p bind subunit B and a peripheral EG stator, mEAK7 contacts EG3 whereas Oxr1p sits next to EG2 (compare left panel in Figure 5A to views in Figure 5B). Moreover, since Oxr1p binds EG2 and subunit B in the state 1 enzyme, its TLDc domain binds the B subunit of the open catalytic site (Figure 5C). In contrast, mEAK7 binds EG3 and the B subunit that is part of a closed catalytic site in the state 2 enzyme (Figure 5D, bottom panel), however, due to mEAK7 binding, the B subunit is now in a more open conformation (Figure 5D, top panel), possibly stabilized by mEAK7’s C-terminal a helix. Thus, both Oxr1p and mEAK7 bind B that is in the open conformation. However, because mEAK7 binds next to EG3 its interaction does not involve subunit C. So, why does mEAK7 not bind the same site as Oxr1p? mEAK7 has a large N-terminal extension, which would likely clash with the C subunit. The exclusion of subunit C from the binding interface may explain why mEAK7 does not lead to V-ATPase dissociation, contrary to Oxr1p’s interaction with the yeast enzyme. Consistent with this, and also contrary to Oxr1p, binding of mEAK7 appeared to have no significant effect on V-ATPase activity.[38] As mentioned, a recent study showed that five mammalian TLDc family members were able to co-immunoprecipitate with the V-ATPase.[36] Thus, the TLDc domain can be classified as a V-ATPase interaction module, with the various N- or C-terminal extensions likely mediating different effects on enzyme function that favor similar but distinct binding sites on the enzyme, as seen for mEAK7.
V-ATPase regulation by reversible disassembly
Early data from yeast and insects showed that V-ATPases readily dissociate under certain metabolic conditions - molting (starvation) in larvae of the tobacco moth, Manduca sexta,[10] and glucose withdrawal in baker’s yeast.[9] It was further found that when nutrients are added back, V1 returns to the membrane to restore holoenzyme function, and the process is therefore referred to as reversible disassembly (or dissociation) (Figure 1B, left side). As described above, the activities of V1 and Vo subcomplexes resulting from this V-ATPase regulation were found to be silenced.[12,13,87] This suggested that the assembly state of the V-ATPase is linked to energy metabolism and glucose signaling, with the concomitant activity silencing of the V1 and Vo serving to preserve energy (MgATP) and existing transmembrane proton gradients, respectively. Subsequent studies, however, have painted a more nuanced picture as several environmental conditions were identified that had no obvious link to glucose or ATP levels under which the degree of assembly was significantly altered, such as elevated extracellular pH or salinity.[15,88] V-ATPase reversible disassembly was subsequently found to be conserved in higher animals including mammals, with reversible disassembly observed in specific enzyme populations and/or processes such as dendritic cell maturation,[20] TOR signaling,[21,22] synaptic vesicle loading,[23] and glucose metabolism.[24] Of note, conditions that triggered enzyme disassembly in yeast (glucose starvation)[14] were in some cases conditions that led to the opposite result in mammalian cells,[24] pointing to the convergence of diverse signaling pathways at the level of the enzyme. However, despite extensive characterization of the physiological causes and effects of V-ATPase regulation by reversible disassembly, the molecular mechanisms of the (re)assembly and disassembly steps at the level of the enzyme complex remain poorly understood. The following sections briefly summarize what we know about the processes of regulated disassembly and reassembly.
V-ATPase disassembly —
Studies in yeast showed that glucose withdrawal induced V-ATPase disassembly occurs on a timescale of about ~5 minutes,[89] and that the process requires catalytically competent V-ATPases, as either mutations of residues essential for ATP hydrolysis and proton pumping, or presence of the specific inhibitor Concanamycin A result in hyperassembly.[14] While enzyme dissociation occurs spontaneously in vitro upon MgATP hydrolysis, the process is much slower compared to in vivo disassembly.[90] Besides inhibition of disassembly due to lack of enzyme activity, several instances have been described where disassembly kinetics is altered significantly despite presence of active V-ATPases. For example, mutations in peripheral stalk subunits at positions Arg25 in G[91] and Glu44 in E[92] result in V-ATPases that are highly active but resistant to disassembly. It is likely that these mutations interfere with one of the molecular steps that take place during regulated disassembly, but what these steps may be is not known. Taken together, these observations show that enzyme activity is a necessary, but insufficient prerequisite for efficient disassembly. Moreover, efficient disassembly depends on the presence of intact microtubules.[29,93] While there is evidence for a physical interaction of tubulin with the C subunit, the molecular role of this interaction is not understood. As mentioned above, cryoEM analysis of V-ATPases from yeast and mammalian organisms revealed populations of the enzyme halted in three rotary states 1–3, with state 3 being the least populated.[32,56,59,61] This suggests that state 3 has the highest energy, which led to the proposal that disassembly occurs while the enzyme pauses in that state;[27,56] a speculation supported by the observation that autoinhibited Vo is halted in state 3.[57,58,94] However, it can also be argued that disassembly has to occur in the most abundant state (state 1) for maximum efficiency, and that the conformations observed for autoinhibited V1 (state 2) and Vo (state 3) are adopted subsequent to separation of V1 from Vo. Support for this notion comes from a recent cryoEM study of in vitro assembled yeast V-ATPase, which revealed a similar distribution of rotary states compared to holoenzyme purified from yeast.[32] Since the Vo used for in vitro assembly was in state 3, this indicates that the central rotor becomes mobile once autoinhibition of Vo is relieved and the holoenzyme is formed, even in absence of MgATP.
V-ATPase reassembly —
Along with having a role in V-ATPase biosynthesis, efficient reassembly of yeast V-ATPase requires a chaperone called Regulator of the H+-ATPases of the Vacuolar and Endosomal membranes (RAVE).[95] RAVE is a heterotrimeric protein complex composed of three subunits, Rav1p, Rav2p and Skp1p.[30] Biochemical studies showed that RAVE has multiple binding sites for both V1 and Vo subunits,[96] and it has been suggested that RAVE’s role is to recruit V1 to Vo in a glucose dependent manner.[97] Chaperone complexes with the function of RAVE are also found in higher organisms, including mammals, where they are celled rabconnectins; though the structure of rabconnectins is more diverse due to tissue specific isoforms.[98] In yeast, RAVE is only required for assembly of the Vph1p containing V-ATPases on the vacuole, but not for the Stv1p containing enzymes in the Golgi; thus, loss of the RAVE complex results in only a partial Vma- phenotype.[99] Biochemical experiments showed that RAVE binds the cytosolic domain of Vph1p and that the glucose dependent recruitment of RAVE to the vacuolar membrane depends on a highly conserved amino acid segment near the middle of Rav1p.[97]
A comparison of the structure of the holoenzyme to the structures of the isolated V1 and Vo subcomplexes revealed the conformational changes in the V1-Vo interface that accompany V-ATPase disassembly. As shown for the yeast enzyme, autoinhibited V1 and Vo are in different rotational states that are stabilized by interactions not present in intact V1Vo (HCT:A3B3D/EG2 in V1 and aNT:d in Vo)[26,27] (Figures 3,4). Besides halting fruitless MgATPase activity by isolated V1, and preventing collapse of proton gradients through Vo, these autoinhibited conformations likely serve to prevent spontaneous reassembly when enzyme function is not desired. Indeed, purified V1 and Vo do not assemble with a measurable rate when mixed at physiological pH in vitro.[74,100] For reassembly to occur, these inhibitory conformations have to be reversed. Since in vitro assembly of Vo with active V1(Hchim) is a spontaneous reaction,[32,74] this suggests that the rate limiting step is (i) release of HCT from its inhibitory binding site on V1 and (ii) reversal of the MgADP inhibited conformation. Enzyme assembly, unlike disassembly, does not require catalytically competent V1 or Vo,[14] but whether the structures of inactive mutant enzymes resemble that of the active V-ATPase is not known. As mentioned above, efficient (re)assembly in yeast requires presence of the RAVE complex. However, biochemical experiments have shown that while RAVE accelerates assembly of Vo with V1(Hchim), the chaperone does not facilitate in vitro assembly of Vo with wild type V1.[101] Taken together, this suggests that additional factors are required to overcome V1 autoinhibition. For example, the glycolytic enzymes aldolase[102] and phosphofructokinase[103] have been shown to play a role in reassembly, and while there is evidence that aldolase exerts its role via a physical interaction with V-ATPase’s peripheral stator,[102] the role of phosphofructokinase at the level of the enzyme is not known.
On the physiological role of the V-ATPase-TLDc domain interactions
Human OXR1 (and yeast Oxr1p) were first identified in a screen for proteins that protect against oxidative DNA damage in E. coli,[104] and while there was some initial speculation that OXR1 has anti ROS enzymatic activity, no evidence to support this notion has been found. A follow-up study suggested that the protective activity was contained in a segment of OXR1 N-terminal to the TLDc domain.[105] However, as the shortest splice variant of human OXR1 encodes only the TLDc domain, like in yeast, and the TLDc domain on its own has been shown to rescue a deletion phenotype in animals, this suggests that the V-ATPase interaction is of critical and central importance to the function of this protein family.[41] Notably, the V-ATPase itself has also been linked to the oxidative stress response in yeast.[106] How the stress response and V-ATPase regulation are linked by this family of proteins is an exciting new avenue of research. If mammalian TLDc domain proteins are able to disassemble the V-ATPase, this poses the question how is specificity achieved? Interestingly, in binding studies using mammalian TLDc domain containing proteins, it was found that some display a preference for binding specific B subunit isoforms. Whereas TLDC2 and TBC1D24 interacted only with V-ATPases containing isoform B1, Meak7 interacted with both B1 and B2 isoform-containing V-ATPases.[36] Further, under what cellular circumstances TLDc proteins are employed for V-ATPase regulation is an open question. Several environmental stimuli have been linked to the assembly state of the enzyme, but how these various signals converge on enzyme disassembly remains unclear. Are the multiple inputs linked to a single factor that acts directly on the enzyme? Are there multiple unique factors, each linked to different stimuli or restricted to distinct cellular locations? Since deletion of OXR1 from the yeast genome has no obvious phenotype (aside from a slightly increased sensitivity to oxidative stress),[104] this shows that Oxr1p is unlikely to play an essential role in RAVE catalyzed enzyme assembly. On the other hand, our recent structural and in vitro biochemical studies indicate that Oxr1p has the ability to rapidly dissociate V1 from the vacuolar membrane. However, it remains to be determined in what physiological context Oxr1p’s activity is employed. Several recent studies in animals or mammalian cells revealed an interplay between TLDc proteins and V-ATPase, either through physical interaction, or impairment of V-ATPase function upon TLDc protein deletion or mutation.[37,40,41] Thus, it appeared that the biochemical data obtained in yeast, which pointed to an inhibitory mechanism of Oxr1p, were in contradiction with the physiological data obtained with the animal V-ATPase. To reconcile this apparent inconsistency, we proposed that yeast Oxr1p (and possibly the mammalian TLDc proteins) function in V-ATPase quality control. It has been known for some time that V-ATPase is subject to inhibition due to oxidation of cysteine residues in the enzyme’s catalytic A subunits.[107,108] Because release of V1 from Vo via reversible disassembly requires active enzyme, we speculated that Oxr1p may serve to disassemble damaged V-ATPases by removing inactive V1 that otherwise would occupy functionally competent Vo on the membrane, especially under conditions of oxidative stress. Another possibility is that Oxr1p is directly involved in the reversible disassembly step in vivo, which would pose the question why in vivo disassembly requires ATP hydrolysis on the enzyme; as this would contrast Oxr1p induced dissociation, which occurs in the absence of added nucleotide. Synaptic vesicle (SV) V-ATPase has been shown to disassemble once neurotransmitter loading is complete, and while it has been proposed that the luminal pH may play a role in the disassembly step,[23] the molecular details of the process are not known. Recently, using single-enzyme proton pumping assays, SV-V-ATPase was shown to be regulated by mode-switching between active, leaky, and inactive states; but whether the inactive state was due to reversible disassembly was not explored.[109] Unlike in yeast, where V-ATPase hyper-assembly is without obvious phenotype, preventing disassembly of the SV-enzyme led to inhibition of SV fusion with the presynaptic membrane.[23] Moreover, several TLDc domain-containing proteins have been shown to have an important role in neurological function.[33,34,41] For example, knockout of NCOA7 in mouse was shown to cause neurological defects, with the additional knockout of OXR1 being embryonic lethal.[37] Taken together, these observations raise the possibility that some of the mammalian TLDc domain containing proteins such as NCOA7, OXR1 or TBC1D24 function in the disassembly of the SV-enzyme; a process that is critical for proper synaptic transmission.
Conclusions and future perspectives
Since its discovery more than 25 years ago, tremendous progress has been made in elucidating the molecular mechanism of V-ATPase regulation by reversible disassembly. A major contribution to this progress was from high-resolution structure determination of holo V-ATPases and their V1-ATPase and Vo proton channel subcomplexes from yeast and higher organisms using X-ray crystallography and cryoEM. These studies revealed snapshots of stable intermediates in the “life cycle” of the highly dynamic V-ATPase; structural models that highlight the conformational changes that the enzyme is undergoing during reversible disassembly. The recent discovery of a new player, Oxr1p’s TLDc domain, in yeast V-ATPase regulation has opened a new avenue of V-ATPase regulation, a mechanism that is only beginning to emerge. Important questions include (i) whether binding of Oxr1p is reversible so that Oxr1p disengaged V1 can be recycled to reassemble with Vo when needed, (ii) whether Oxr1p is able to disassemble both active and inactive V-ATPases, or whether one form is preferred, (iii) whether Oxr1p driven disengagement of V1 from Vo is somehow linked to the reversible disassembly process, or whether Oxr1p’s in vitro activity is part of an entirely novel in vivo pathway, and (iv) whether some of the mammalian TLDc proteins share yeast Oxr1p’s ability to disassemble the V-ATPase. There is ample evidence that TLDc domain containing proteins are intimately involved in V-ATPase function and regulation in higher animals, including mammals, but how these proteins perform their task at the level of the enzyme is largely unknown. From comparing Oxr1p’s and mEAK7’s binding sites and the proteins’ effect on holoenzyme function and integrity, it seems clear that while different TLDc proteins likely share the general mode of interaction with the enzyme, their effect on V-ATPase regulation may vary depending on the nature of the TLDc proteins’ N- and C-terminal extensions and the isoform composition and intracellular location of the V-ATPase.
Acknowledgement
Work in S.W.’s laboratory is supported by NIH/NIGMS grant GM141908.
Footnotes
Conflict of interest
The authors declare that they have no conflict of interest.
Of note, both yeast and insect V1 can hydrolyze CaATP, but the activity is suppressed by the presence of even trace amounts of Mg2+ in the assay.
The interface between HCT and the N-termini of EG seen in the cryoEM structure is also observed in the crystal structure, but it involves HCT and EG from two symmetry related V1 complexes.
IFI44 is unusual in that its TLDc domain comprises the N-terminus of the ~440 residue polypeptide.
Data availability
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
References
- 1.Collins MP, Forgac M. 2020. Regulation and function of V-ATPases in physiology and disease. Biochim Biophys Acta Biomembr 1862: 183341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Eaton AF, Merkulova M, Brown D. 2021. The H(+)-ATPase (V-ATPase): from proton pump to signaling complex in health and disease. Am J Physiol Cell Physiol 320: C392–C414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Marshansky V, Futai M. 2008. The V-type H+-ATPase in vesicular trafficking: targeting, regulation and function. Curr Opin Cell Biol 20: 415–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Maxson ME, Grinstein S. 2014. The vacuolar-type H(+)-ATPase at a glance - more than a proton pump. J Cell Sci 127: 4987–93. [DOI] [PubMed] [Google Scholar]
- 5.Santos-Pereira C, Rodrigues LR, Côrte-Real M. 2021. Emerging insights on the role of V-ATPase in human diseases: Therapeutic challenges and opportunities. Med Res Rev. [DOI] [PubMed] [Google Scholar]
- 6.Harrison MA, Muench SP. 2018. The Vacuolar ATPase - A Nano-scale Motor That Drives Cell Biology. Subcell Biochem 87: 409–59. [DOI] [PubMed] [Google Scholar]
- 7.Futai M, Nakanishi-Matsui M, Okamoto H, Sekiya M, Nakamoto RK. 2012. Rotational catalysis in proton pumping ATPases: from E. coli F-ATPase to mammalian V-ATPase. Biochim Biophys Acta 1817: 1711–21. [DOI] [PubMed] [Google Scholar]
- 8.Stewart AG, Sobti M, Harvey RP, Stock D. 2013. Rotary ATPases: models, machine elements and technical specifications. Bioarchitecture 3: 2–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kane PM. 1995. Disassembly and reassembly of the yeast vacuolar H(+)-ATPase in vivo. J Biol Chem 270: 17025–32. [PubMed] [Google Scholar]
- 10.Sumner JP, Dow JA, Earley FG, Klein U, Jager D, Wieczorek H. 1995. Regulation of plasma membrane V-ATPase activity by dissociation of peripheral subunits. J Biol Chem 270: 5649–53. [DOI] [PubMed] [Google Scholar]
- 11.Graf R, Harvey WR, Wieczorek H. 1996. Purification and properties of a cytosolic V1-ATPase. J Biol Chem 271: 20908–13. [DOI] [PubMed] [Google Scholar]
- 12.Parra KJ, Keenan KL, Kane PM. 2000. The H subunit (Vma13p) of the yeast V-ATPase inhibits the ATPase activity of cytosolic V1 complexes. J Biol Chem 275: 21761–7. [DOI] [PubMed] [Google Scholar]
- 13.Zhang J, Feng Y, Forgac M. 1994. Proton conduction and bafilomycin binding by the V0 domain of the coated vesicle V-ATPase. J Biol Chem 269: 23518–23. [PubMed] [Google Scholar]
- 14.Parra KJ, Kane PM. 1998. Reversible association between the V1 and V0 domains of yeast vacuolar H+-ATPase is an unconventional glucose-induced effect. Mol Cell Biol 18: 7064–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Diakov TT, Kane PM. 2010. Regulation of vacuolar proton-translocating ATPase activity and assembly by extracellular pH. J Biol Chem 285: 23771–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Marjuki H, Gornitzky A, Marathe BM, Ilyushina NA, Aldridge JR, Desai G, . . . Webster RG. 2011. Influenza A virus-induced early activation of ERK and PI3K mediates V-ATPase-dependent intracellular pH change required for fusion. Cell Microbiol 13: 587–601. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Sautin YY, Lu M, Gaugler A, Zhang L, Gluck SL. 2005. Phosphatidylinositol 3-kinase-mediated effects of glucose on vacuolar H+-ATPase assembly, translocation, and acidification of intracellular compartments in renal epithelial cells. Mol Cell Biol 25: 575–89. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Dames P, Zimmermann B, Schmidt R, Rein J, Voss M, Schewe B, . . . Baumann O. 2006. cAMP regulates plasma membrane vacuolar-type H+-ATPase assembly and activity in blowfly salivary glands. Proc Natl Acad Sci U S A 103: 3926–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Collins MP, Stransky LA, Forgac M. 2020. AKT Ser/Thr kinase increases V-ATPase-dependent lysosomal acidification in response to amino acid starvation in mammalian cells. J Biol Chem 295: 9433–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Trombetta ES, Ebersold M, Garrett W, Pypaert M, Mellman I. 2003. Activation of lysosomal function during dendritic cell maturation. Science 299: 1400–3. [DOI] [PubMed] [Google Scholar]
- 21.Zoncu R, Bar-Peled L, Efeyan A, Wang S, Sancak Y, Sabatini DM. 2011. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 334: 678–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Ratto E, Chowdhury SR, Siefert NS, Schneider M, Wittmann M, Helm D, Palm W. 2022. Direct control of lysosomal catabolic activity by mTORC1 through regulation of V-ATPase assembly. Nat Commun 13: 4848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Bodzeta A, Kahms M, Klingauf J. 2017. The Presynaptic v-ATPase Reversibly Disassembles and Thereby Modulates Exocytosis but Is Not Part of the Fusion Machinery. Cell Rep 20: 1348–59. [DOI] [PubMed] [Google Scholar]
- 24.McGuire CM, Forgac M. 2018. Glucose starvation increases V-ATPase assembly and activity in mammalian cells through AMP kinase and phosphatidylinositide 3-kinase/Akt signaling. J Biol Chem 293: 9113–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.McGuire C, Stransky L, Cotter K, Forgac M. 2017. Regulation of V-ATPase activity. Front Biosci (Landmark Ed) 22: 609–22. [DOI] [PubMed] [Google Scholar]
- 26.Oot RA, Couoh-Cardel S, Sharma S, Stam NJ, Wilkens S. 2017. Breaking up and making up: The secret life of the vacuolar H+ -ATPase. Protein Sci 26: 896–909. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Vasanthakumar T, Keon KA, Bueler SA, Jaskolka MC, Rubinstein JL. 2022. Coordinated conformational changes in the V(1) complex during V-ATPase reversible dissociation. Nat Struct Mol Biol 29: 430–9. [DOI] [PubMed] [Google Scholar]
- 28.Huss M, Wieczorek H. 2007. Influence of ATP and ADP on dissociation of the V-ATPase into its V(1) and V(O) complexes. FEBS Lett 581: 5566–72. [DOI] [PubMed] [Google Scholar]
- 29.Xu T, Forgac M. 2001. Microtubules are involved in glucose-dependent dissociation of the yeast vacuolar [H+]-ATPase in vivo. J Biol Chem 276: 24855–61. [DOI] [PubMed] [Google Scholar]
- 30.Seol JH, Shevchenko A, Shevchenko A, Deshaies RJ. 2001. Skp1 forms multiple protein complexes, including RAVE, a regulator of V-ATPase assembly. Nat Cell Biol 3: 384–91. [DOI] [PubMed] [Google Scholar]
- 31.Smardon AM, Tarsio M, Kane PM. 2002. The RAVE complex is essential for stable assembly of the yeast V-ATPase. J Biol Chem 277: 13831–9. [DOI] [PubMed] [Google Scholar]
- 32.Khan MM, Lee S, Couoh-Cardel S, Oot RA, Kim H, Wilkens S, Roh SH. 2022. Oxidative stress protein Oxr1 promotes V-ATPase holoenzyme disassembly in catalytic activity-independent manner. EMBO J 41: e109360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Finelli MJ, Sanchez-Pulido L, Liu KX, Davies KE, Oliver PL. 2016. The Evolutionarily Conserved Tre2/Bub2/Cdc16 (TBC), Lysin Motif (LysM), Domain Catalytic (TLDc) Domain Is Neuroprotective against Oxidative Stress. J Biol Chem 291: 2751–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Finelli MJ, Oliver PL. 2017. TLDc proteins: new players in the oxidative stress response and neurological disease. Mamm Genome 28: 395–406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Merkulova M, Păunescu TG, Azroyan A, Marshansky V, Breton S, Brown D. 2015. Mapping the H(+) (V)-ATPase interactome: identification of proteins involved in trafficking, folding, assembly and phosphorylation. Sci Rep 5: 14827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Eaton AF, Brown D, Merkulova M. 2021. The evolutionary conserved TLDc domain defines a new class of (H(+))V-ATPase interacting proteins. Sci Rep 11: 22654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Castroflorio E, den Hoed J, Svistunova D, Finelli MJ, Cebrian-Serrano A, Corrochano S, . . . Oliver PL. 2021. The Ncoa7 locus regulates V-ATPase formation and function, neurodevelopment and behaviour. Cell Mol Life Sci 78: 3503–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Wang R, Qin Y, Xie XS, Li X. 2022. Molecular basis of mEAK7-mediated human V-ATPase regulation. Nat Commun 13: 3272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Tan YZ, Abbas YM, Wu JZ, Wu D, Keon KA, Hesketh GG, . . . Rubinstein JL. 2022. CryoEM of endogenous mammalian V-ATPase interacting with the TLDc protein mEAK-7. Life Sci Alliance 5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Merkulova M, Păunescu TG, Nair AV, Wang CY, Capen DE, Oliver PL, … Brown D 2018. Targeted deletion of the Ncoa7 gene results in incomplete distal renal tubular acidosis in mice. Am J Physiol Renal Physiol 315: F173–F85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Wang J, Rousseau J, Kim E, Ehresmann S, Cheng YT, Duraine L, … Campeau PM. 2019. Loss of Oxidation Resistance 1, OXR1, Is Associated with an Autosomal-Recessive Neurological Disease with Cerebellar Atrophy and Lysosomal Dysfunction. Am J Hum Genet 105: 1237–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Iino R, Minagawa Y, Ueno H, Hara M, Murata T. 2014. Molecular structure and rotary dynamics of Enterococcus hirae V₁-ATPase. IUBMB Life 66: 624–30. [DOI] [PubMed] [Google Scholar]
- 43.Murata T, Yamato I, Kakinuma Y. 2005. Structure and mechanism of vacuolar Na+-translocating ATPase from Enterococcus hirae. J Bioenerg Biomembr 37: 411–3. [DOI] [PubMed] [Google Scholar]
- 44.Forgac M 2007. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 8: 917–29. [DOI] [PubMed] [Google Scholar]
- 45.Inoue H, Noumi T, Nagata M, Murakami H, Kanazawa H. 1999. Targeted disruption of the gene encoding the proteolipid subunit of mouse vacuolar H(+)-ATPase leads to early embryonic lethality. Biochim Biophys Acta 1413: 130–8. [DOI] [PubMed] [Google Scholar]
- 46.Nelson H, Nelson N. 1990. Disruption of genes encoding subunits of yeast vacuolar H(+)-ATPase causes conditional lethality. Proc Natl Acad Sci U S A 87: 3503–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zhang Z, Zheng Y, Mazon H, Milgrom E, Kitagawa N, Kish-Trier E, … Wilkens S 2008. Structure of the yeast vacuolar ATPase. J Biol Chem 283: 35983–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Diepholz M, Venzke D, Prinz S, Batisse C, Florchinger B, Rossle M, … Fethiere J 2008. A different conformation for EGC stator subcomplex in solution and in the assembled yeast V-ATPase: possible implications for regulatory disassembly. Structure 16: 1789–98. [DOI] [PubMed] [Google Scholar]
- 49.Wilkens S, Inoue T, Forgac M. 2004. Three-dimensional structure of the vacuolar ATPase. Localization of subunit H by difference imaging and chemical cross-linking. J Biol Chem 279: 41942–9. [DOI] [PubMed] [Google Scholar]
- 50.Sagermann M, Stevens TH, Matthews BW. 2001. Crystal structure of the regulatory subunit H of the V-type ATPase of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 98: 7134–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Drory O, Frolow F, Nelson N. 2004. Crystal structure of yeast V-ATPase subunit C reveals its stator function. EMBO Rep 5: 1148–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Oot RA, Huang LS, Berry EA, Wilkens S. 2012. Crystal structure of the yeast vacuolar ATPase heterotrimeric EGC(head) peripheral stalk complex. Structure 20: 1881–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Oot RA, Kane PM, Berry EA, Wilkens S. 2016. Crystal structure of yeast V1-ATPase in the autoinhibited state. EMBO J 35: 1694–706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Balakrishna AM, Basak S, Manimekalai MS, Gruber G. 2015. Crystal structure of subunits D and F in complex gives insight into energy transmission of the eukaryotic V-ATPase from Saccharomyces cerevisiae. J Biol Chem 290: 3183–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Basak S, Lim J, Manimekalai MS, Balakrishna AM, Gruber G. 2013. Crystal and NMR structures give insights into the role and dynamics of subunit F of the eukaryotic V-ATPase from Saccharomyces cerevisiae. J Biol Chem 288: 11930–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Zhao J, Benlekbir S, Rubinstein JL. 2015. Electron cryomicroscopy observation of rotational states in a eukaryotic V-ATPase. Nature 521: 241–5. [DOI] [PubMed] [Google Scholar]
- 57.Mazhab-Jafari MT, Rohou A, Schmidt C, Bueler SA, Benlekbir S, Robinson CV, Rubinstein JL. 2016. Atomic model for the membrane-embedded VO motor of a eukaryotic V-ATPase. Nature 539: 118–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Roh SH, Stam NJ, Hryc CF, Couoh-Cardel S, Pintilie G, Chiu W, Wilkens S. 2018. The 3.5-A CryoEM Structure of Nanodisc-Reconstituted Yeast Vacuolar ATPase Vo Proton Channel. Mol Cell 69: 993–1004 e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Abbas YM, Wu D, Bueler SA, Robinson CV, Rubinstein JL. 2020. Structure of V-ATPase from the mammalian brain. Science 367: 1240–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Wang R, Long T, Hassan A, Wang J, Sun Y, Xie XS, Li X. 2020. Cryo-EM structures of intact V-ATPase from bovine brain. Nat Commun 11: 3921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Wang L, Wu D, Robinson CV, Wu H, Fu TM. 2020. Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly. Mol Cell 80: 501–11 e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Tan YZ, Keon KA, Abdelaziz R, Imming P, Schulze W, Schumacher K, Rubinstein JL. 2022. Structure of V-ATPase from citrus fruit. Structure 30: 1403–10 e4. [DOI] [PubMed] [Google Scholar]
- 63.Wilkens S, Oot RA, Khan MM, Zimmer K. 2021. Structure and Mechanism of the Vacuolar H+ -ATPase. Jez Joseph (eds) Encyclopedia of Biological Chemistry, 3rd Edition. p 581–93. [Google Scholar]
- 64.Vasanthakumar T, Rubinstein JL. 2020. Structure and Roles of V-type ATPases. Trends Biochem Sci 45: 295–307. [DOI] [PubMed] [Google Scholar]
- 65.Smith GA, Howell GJ, Phillips C, Muench SP, Ponnambalam S, Harrison MA. 2016. Extracellular and Luminal pH Regulation by Vacuolar H+-ATPase Isoform Expression and Targeting to the Plasma Membrane and Endosomes. J Biol Chem 291: 8500–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Ryan M, Graham LA, Stevens TH. 2008. Voa1p functions in V-ATPase assembly in the yeast endoplasmic reticulum. Mol Biol Cell 19: 5131–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Manolson MF, Wu B, Proteau D, Taillon BE, Roberts BT, Hoyt MA, Jones EW. 1994. STV1 gene encodes functional homologue of 95-kDa yeast vacuolar H(+)-ATPase subunit Vph1p. J Biol Chem 269: 14064–74. [PubMed] [Google Scholar]
- 68.Kawasaki-Nishi S, Bowers K, Nishi T, Forgac M, Stevens TH. 2001. The amino-terminal domain of the vacuolar proton-translocating ATPase a subunit controls targeting and in vivo dissociation, and the carboxyl-terminal domain affects coupling of proton transport and ATP hydrolysis. J Biol Chem 276: 47411–20. [DOI] [PubMed] [Google Scholar]
- 69.Qi J, Forgac M. 2007. Cellular environment is important in controlling V-ATPase dissociation and its dependence on activity. J Biol Chem 282: 24743–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Toei M, Saum R, Forgac M. 2010. Regulation and isoform function of the V-ATPases. Biochemistry 49: 4715–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Toei M, Toei S, Forgac M. 2011. Definition of membrane topology and identification of residues important for transport in subunit a of the vacuolar ATPase. J Biol Chem 286: 35176–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Uchida E, Ohsumi Y, Anraku Y. 1985. Purification and properties of H+-translocating, Mg2+-adenosine triphosphatase from vacuolar membranes of Saccharomyces cerevisiae. J Biol Chem 260: 1090–5. [PubMed] [Google Scholar]
- 73.Cingolani G, Duncan TM. 2011. Structure of the ATP synthase catalytic complex (F(1)) from Escherichia coli in an autoinhibited conformation. Nat Struct Mol Biol 18: 701–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Sharma S, Oot RA, Khan MM, Wilkens S. 2019. Functional reconstitution of vacuolar H+-ATPase from Vo proton channel and mutant V1-ATPase provides insight into the mechanism of reversible disassembly. J Biol Chem 294: 6439–49. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Roh SH, Shekhar M, Pintilie G, Chipot C, Wilkens S, Singharoy A, Chiu W. 2020. Cryo-EM and MD infer water-mediated proton transport and autoinhibition mechanisms of V(o) complex. Sci Adv 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Schneider E, Altendorf K. 1985. All three subunits are required for the reconstitution of an active proton channel (F0) of Escherichia coli ATP synthase (F1F0). EMBO J 4: 515–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Wilkens S, Zhang Z, Zheng Y. 2005. A structural model of the vacuolar ATPase from transmission electron microscopy. Micron 36: 109–26. [DOI] [PubMed] [Google Scholar]
- 78.Couoh-Cardel S, Milgrom E, Wilkens S. 2015. Affinity Purification and Structural Features of the Yeast Vacuolar ATPase Vo Membrane Sector. J Biol Chem 290: 27959–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Ouyang Z, Li Z, Zhang X. 2008. Cloning and sequencing of V-ATPase subunit d from mung bean and its function in passive proton transport. J Bioenerg Biomembr 40: 569–76. [DOI] [PubMed] [Google Scholar]
- 80.Crider BP, Xie XS, Stone DK. 1994. Bafilomycin inhibits proton flow through the H+ channel of vacuolar proton pumps. J Biol Chem 269: 17379–81. [PubMed] [Google Scholar]
- 81.Oot RA, Wilkens S. 2010. Domain characterization and interaction of the yeast vacuolar ATPase subunit C with the peripheral stator stalk subunits E and G. J Biol Chem 285: 24654–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Oot RA, Wilkens S. 2012. Subunit interactions at the V1-Vo interface in yeast vacuolar ATPase. J Biol Chem 287: 13396–406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Oliver PL, Finelli MJ, Edwards B, Bitoun E, Butts DL, Becker EB, … Davies KE. 2011. Oxr1 is essential for protection against oxidative stress-induced neurodegeneration. PLoS Genet 7: e1002338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Volkert MR, Crowley DJ. 2020. Preventing Neurodegeneration by Controlling Oxidative Stress: The Role of OXR1. Front Neurosci 14: 611904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Yu L, Croze E, Yamaguchi KD, Tran T, Reder AT, Litvak V, Volkert MR. 2015. Induction of a unique isoform of the NCOA7 oxidation resistance gene by interferon β−1b. J Interferon Cytokine Res 35: 186–99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Wang L, Wu D, Robinson CV, Fu TM. 2022. Identification of mEAK-7 as a human V-ATPase regulator via cryo-EM data mining. Proc Natl Acad Sci U S A 119: e2203742119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Zhang Z, Charsky C, Kane PM, Wilkens S. 2003. Yeast V1-ATPase: affinity purification and structural features by electron microscopy. J Biol Chem 278: 47299–306. [DOI] [PubMed] [Google Scholar]
- 88.Li SC, Diakov TT, Rizzo JM, Kane PM. 2012. Vacuolar H+-ATPase works in parallel with the HOG pathway to adapt Saccharomyces cerevisiae cells to osmotic stress. Eukaryot Cell 11: 282–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Dechant R, Binda M, Lee SS, Pelet S, Winderickx J, Peter M. 2010. Cytosolic pH is a second messenger for glucose and regulates the PKA pathway through V-ATPase. EMBO J 29: 2515–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Sharma S, Wilkens S. 2017. Biolayer interferometry of lipid nanodisc-reconstituted yeast vacuolar H+ -ATPase. Protein Sci 26: 1070–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Charsky CM, Schumann NJ, Kane PM. 2000. Mutational analysis of subunit G (Vma10p) of the yeast vacuolar H+-ATPase. J Biol Chem 275: 37232–9. [DOI] [PubMed] [Google Scholar]
- 92.Okamoto-Terry H, Umeki K, Nakanishi-Matsui M, Futai M. 2013. Glu-44 in the amino-terminal α-helix of yeast vacuolar ATPase E subunit (Vma4p) has a role for VoV1 assembly. J Biol Chem 288: 36236–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Tabke K, Albertmelcher A, Vitavska O, Huss M, Schmitz HP, Wieczorek H. 2014. Reversible disassembly of the yeast V-ATPase revisited under in vivo conditions. Biochem J. [DOI] [PubMed] [Google Scholar]
- 94.Stam NJ, Wilkens S. 2016. Structure of Nanodisc Reconstituted Vacuolar ATPase Proton Channel: Definition of the Interaction of Rotor and Stator and Implications for Enzyme Regulation by Reversible Dissociation. J Biol Chem. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Smardon AM, Kane PM. 2007. RAVE is essential for the efficient assembly of the C subunit with the vacuolar H(+)-ATPase. J Biol Chem 282: 26185–94. [DOI] [PubMed] [Google Scholar]
- 96.Smardon AM, Nasab ND, Tarsio M, Diakov TT, Kane PM. 2015. Molecular Interactions and Cellular Itinerary of the Yeast RAVE (Regulator of the H+-ATPase of Vacuolar and Endosomal Membranes) Complex. J Biol Chem. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Jaskolka MC, Kane PM. 2020. Interaction between the yeast RAVE complex and Vph1-containing V(o) sectors is a central glucose-sensitive interaction required for V-ATPase reassembly. J Biol Chem 295: 2259–69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Jaskolka MC, Winkley SR, Kane PM. 2021. RAVE and Rabconnectin-3 Complexes as Signal Dependent Regulators of Organelle Acidification. Front Cell Dev Biol 9: 698190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Smardon AM, Diab HI, Tarsio M, Diakov TT, Nasab ND, West RW, Kane PM. 2014. The RAVE complex is an isoform-specific V-ATPase assembly factor in yeast. Mol Biol Cell 25: 356–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Parra KJ, Kane PM. 1996. Wild-type and mutant vacuolar membranes support pH-dependent reassembly of the yeast vacuolar H+-ATPase in vitro. J Biol Chem 271: 19592–8. [DOI] [PubMed] [Google Scholar]
- 101.Jaskolka MC, Tarsio M, Smardon AM, Khan MM, Kane PM. 2021. Defining steps in RAVE-catalyzed V-ATPase assembly using purified RAVE and V-ATPase subcomplexes. J Biol Chem 296: 100703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Lu M, Ammar D, Ives H, Albrecht F, Gluck SL. 2007. Physical interaction between aldolase and vacuolar H+-ATPase is essential for the assembly and activity of the proton pump. J Biol Chem 282: 24495–503. [DOI] [PubMed] [Google Scholar]
- 103.Chan CY, Parra KJ. 2014. Yeast phosphofructokinase-1 subunit Pfk2p is necessary for pH homeostasis and glucose-dependent vacuolar ATPase reassembly. J Biol Chem 289: 19448–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Volkert MR, Elliott NA, Housman DE. 2000. Functional genomics reveals a family of eukaryotic oxidation protection genes. Proc Natl Acad Sci U S A 97: 14530–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Murphy KC, Volkert MR. 2012. Structural/functional analysis of the human OXR1 protein: identification of exon 8 as the anti-oxidant encoding function. BMC Mol Biol 13: 26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Milgrom E, Diab H, Middleton F, Kane PM. 2007. Loss of vacuolar proton-translocating ATPase activity in yeast results in chronic oxidative stress. J Biol Chem 282: 7125–36. [DOI] [PubMed] [Google Scholar]
- 107.Feng Y, Forgac M. 1992. A novel mechanism for regulation of vacuolar acidification. J Biol Chem 267: 19769–72. [PubMed] [Google Scholar]
- 108.Oluwatosin YE, Kane PM. 1997. Mutations in the CYS4 gene provide evidence for regulation of the yeast vacuolar H+-ATPase by oxidation and reduction in vivo. J Biol Chem 272: 28149–57. [DOI] [PubMed] [Google Scholar]
- 109.Kosmidis E, Shuttle CG, Preobraschenski J, Ganzella M, Johnson PJ, Veshaguri S, … Stamou D. 2022. Regulation of the mammalian-brain V-ATPase through ultraslow mode-switching. Nature 611: 827–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
